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While otologic complaints are a common reason for patients to
present to an otolaryngologist, Eustachian tube dysfunction (ETD)
remains a poorly understood disease whose management is
unclear. Among the general population in the United States, ETD
has a prevalence of 4.6% among adults and 6.1% among children.1
Eustachian tube dysfunction is not just a common diagnosis for
otolaryngologists, ETD accounted for 2 million visits for patients
less than 20 years old to primary care providers and over 2 million
visits for patients older than 20 years old between 2005 and 2012.2
Despite the commonality of ETD, opinions differ wildly among
otolaryngologist on the management of these patients.
One of the issues faced by otolaryngologists and primary care
providers alike is the difficulty in clarifying the diagnosis of ETD.
Patients will often present with aural fullness, popping, pain,
pressure, clogging, and underwater sensation.3 The first challenge
faced after a clinician suspects a diagnosis of ETD is to determine
what type of ETD the patient may be experiencing. The patient
history is key as is an appropriately focused physical examination
and workup which considers 3 categories of ETD: (1) dilatory
ETD, (2) Baro-challenge-induced ETD, (3) Patulous ETD.
Acute dilatory or obstructive ETD is commonly preceded by
an upper respiratory infection or allergic rhinitis. Patients will
report aural fullness and popping. There may be an associated
otitis media. Chronic dilatory ETD is a long-standing presence
of similar symptoms, typically not associated with an acute
illness, though they may be exacerbated by one. Barochallenge-induced ETD is brought on by changes in the ambient pressure. The patients usually are asymptomatic until a
change in ambient pressure occurs. Scuba divers and flight
crews are not infrequently afflicted. Patulous ETD is often
misdiagnosed as dilatory ETD or baro-trauma-induced ETD.
The distinguishing symptom of patulous ETD versus the other
types is the presence of autophony.4 This editorial will primarily focus on dilatory and baro-trauma-induced ETD.
The diagnose of dilatory ETD is typically made based on the
patients reported symptoms as well as negative pressure in the

ear based on clinical assessment, whether it be by tympanometry, otoscopy, or otomicroscopy. Baro-challenge-induced ETD
is a diagnosis made based on patient history. Abnormal physical examination findings will typically be absent. The diagnoses of patulous ETD will also largely depend on the patient’s
history. Although, most commonly, the tympanic membrane
and middle ear will appear normal, excursions of the tympanic
membrane may be appreciated with ipsilateral nasal respiration
performed while upright. A careful history is required to identify those patients who have or are suspected to have patulous
ETD, as their treatment differs greatly from the others.
The management of ETD may be as challenging as its diagnosis. The first approach generally is to address the underlying
cause or causes of ETD. Mucosal edema at the Eustachian tube
orifice has been noted in 83% of patients with ETD.5 There is a
strong correlation between mucosal inflammation and laryngopharyngeal reflux and allergic rhinitis.6 Because of this association, it is common practice to prescribe nasal steroids as
first-line treatment for ETD. A study by Wang et al in 2017
showed that otolaryngologists continue to prescribe nasal steroids for the treatment of otitis media with effusion, despite
level I evidence that intranasal steroids are no more effective
than placebo in the treatment of ETD.7,8 The decision to prescribe nasal steroids should be made to specifically treat an
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associated condition thought to be contributing to ETD and not
specifically to treat only ETD.
Traditionally, the gold standard for the treatment of ETD has
been the placement of short-term ventilating tubes (VTs). Often
the results are satisfactory but just as often once the short-term
VT extrudes patients may require additional short-term VTs or
sometimes long-term tubes. Patients are often left wondering if
there is a more permanent and physiologic option. This demand
has led to the development of many different tuboplasty procedures have been trialed including via nasopharynx, middle ear,
preauricular, and middle cranial fossa approaches.
The otolaryngologist’s familiarity with nasal endoscopy has
led to the development of these new treatment options for ETD.
In 2004, Kujawki and Poe described laser Eustachian tuboplasty
via a mixed oropharyngeal and endoscopic approach but overall
the results were mixed.9,10 In 2007, Metson et al performed a
microdebrider tuboplasty on 20 patients already undergoing
endoscopic sinus surgery who also had concurrent ETD. They
reported an improvement in symptoms in 70% of their cohort.11
In the modern era of balloons and sinonasal endoscopy, otolaryngologists have taken the logical step of combining the 2 to
treat ETD. In 2010, Ockerman et al published the first study
which explored the idea of the using sinus balloons to dilate the
Eustachian tube.12 The study of balloon dilation of the Eustachian tube (BDET) has since expanded to larger trials. Poe et al
conducted a randomized prospective trial comparing BDET with
medical management (MM) versus MM alone. In those that
underwent BDET þ MM, 51.8% experienced normalization of
tympanograms at 6 weeks, versus 13.9% of the control, and
62.2% experienced normalization of their tympanograms at 24
weeks, versus 8.5% of controls.13 A follow-up study showed that
these results were durable through 52 weeks.14
Given all of these available options, the question remains,
what is the best treatment for patients with ETD? The first step
we would recommend is to educate the patient on the natural
history of the disease and attempt to diagnose and treat any
underlying cause such as allergic rhinitis. In our opinions, the
2 best and safest options once conservative measures fail are
VTs and BDET. Some patients will gravitate toward the definitive nature to VTs and some patients will gravitate toward the
physiologic nature of BDET. Typically, the patients we find that
decide on BDET are those who have undergone several sets of
myringotomy tubes and are looking for an alternative. They
express understanding that BDET may not work for them, but
they are often willing to try it if it means possibly not requiring
another sent of VTs. Of course, there is paucity of long-term data
at this time, but again, as long as the patient understands that, we
feel it is reasonable to offer BDET as an alternative to VTs.
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